{"id":"methadone-pill","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Constipation"},{"rate":"20-30","effect":"Sweating"},{"rate":"15-25","effect":"Sedation"},{"rate":"10-20","effect":"Nausea"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"QT prolongation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methadone acts as a full agonist at mu opioid receptors, producing effects similar to morphine but with a longer half-life (24-36 hours), which allows for once-daily dosing. It is primarily used in opioid use disorder treatment to prevent withdrawal symptoms and reduce cravings, and secondarily for chronic pain management. The extended duration of action makes it particularly suitable for maintenance therapy in opioid addiction.","oneSentence":"Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and reduce withdrawal symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:42.780Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Opioid use disorder maintenance treatment"},{"name":"Chronic pain management"},{"name":"Opioid withdrawal prevention"}]},"trialDetails":[{"nctId":"NCT06521476","phase":"PHASE2","title":"Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder","status":"RECRUITING","sponsor":"Sanjay R Patel","startDate":"2025-09-30","conditions":"Central Sleep Apnea Comorbid With Opioid Use","enrollment":40},{"nctId":"NCT06351215","phase":"PHASE3","title":"PO Methadone Ortho Outpatient","status":"NOT_YET_RECRUITING","sponsor":"Keck School of Medicine of USC","startDate":"2025-05-01","conditions":"Arthroscopic Knee Repair, Arthroscopic Hip Repair","enrollment":100},{"nctId":"NCT01857245","phase":"NA","title":"Intensive Models of HCV Care for Injection Drug Users","status":"COMPLETED","sponsor":"Prisma Health-Upstate","startDate":"2013-10-01","conditions":"Hepatitis C, Medication Adherence","enrollment":150},{"nctId":"NCT02929589","phase":"PHASE3","title":"Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy","status":"TERMINATED","sponsor":"Mike O'Callaghan Military Hospital","startDate":"2018-07-05","conditions":"Pain, Hernia","enrollment":18},{"nctId":"NCT04941443","phase":"PHASE4","title":"Methadone and Medication Abortion","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2021-10-04","conditions":"Pain, Medical Abortion","enrollment":4},{"nctId":"NCT00838981","phase":"PHASE1, PHASE2","title":"Pharmacotherapy & CM for Opioid and Cocaine Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-05","conditions":"Cocaine Dependence","enrollment":91},{"nctId":"NCT01027754","phase":"PHASE4","title":"Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2009-08","conditions":"Smoking Cessation, Substance-Related Disorders","enrollment":112},{"nctId":"NCT03254043","phase":"NA","title":"Evaluating a Novel Medication Device for Methadone Dosing","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-01-31","conditions":"Opioid-use Disorder","enrollment":26},{"nctId":"NCT02941809","phase":"NA","title":"Harnessing Placebo Effects in Methadone Treatment","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-05","conditions":"Opioid-use Disorder, Opioid-Related Disorders","enrollment":133},{"nctId":"NCT00566969","phase":"NA","title":"Cocaine Withdrawal and Pharmacotherapy Response","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-09","conditions":"Cocaine Dependence, Opiate Dependence","enrollment":106},{"nctId":"NCT00567320","phase":"NA","title":"Efficacy of Varenicline in Methadone-Stabilized Cocaine Users","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-03","conditions":"Cocaine Dependence, Nicotine Dependence","enrollment":31},{"nctId":"NCT02359006","phase":"NA","title":"The Effects of Minocycline in Opioid-maintained Patients","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-03-12","conditions":"Opioid Dependence, Pain","enrollment":27},{"nctId":"NCT00420771","phase":"PHASE2","title":"Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2007-01","conditions":"Benzodiazepine Dependence, Opioid Dependence","enrollment":19},{"nctId":"NCT01650649","phase":"PHASE1","title":"Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2012-07","conditions":"Opioid Dependence, Methadone Withdrawal Syndrome","enrollment":27},{"nctId":"NCT00149630","phase":"PHASE2","title":"Pharmacogenetics of Disulfiram for Cocaine","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2005-01","conditions":"Cocaine Dependence, Opioid Dependence","enrollment":93},{"nctId":"NCT01802515","phase":"NA","title":"A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment","status":"TERMINATED","sponsor":"Yale University","startDate":"2012-12","conditions":"Cocaine Dependence, Opiate Dependence","enrollment":14},{"nctId":"NCT00253890","phase":"PHASE3","title":"Insomnia and Drug Relapse Risk","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2005-10","conditions":"Poor Quality Sleep, Opiate Addiction","enrollment":137},{"nctId":"NCT01752699","phase":"PHASE3","title":"Methadone in Post-Herpetic Neuralgia Pain","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"1998-01","conditions":"Post-herpetic Neuralgia","enrollment":10},{"nctId":"NCT01068847","phase":"PHASE1","title":"Drug Discrimination in Methadone-Maintained Humans Study 3","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2010-02","conditions":"Drug Dependence","enrollment":9},{"nctId":"NCT00733239","phase":"PHASE1","title":"Drug Discrimination in Methadone-Maintained Humans Study 2","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2008-08","conditions":"Opioid Dependence","enrollment":15},{"nctId":"NCT00593463","phase":"PHASE1","title":"Drug Discrimination in Methadone-Maintained Humans Study 1","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2006-09","conditions":"Drug Dependence","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CHEST PAIN"},{"count":1,"reaction":"NAUSEA"},{"count":1,"reaction":"PRURITUS"},{"count":1,"reaction":"TREMOR"},{"count":1,"reaction":"VOMITING"}],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Methadone Hydrochloride"],"phase":"marketed","status":"active","brandName":"Methadone Pill","genericName":"Methadone Pill","companyName":"Boston Medical Center","companyId":"boston-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and reduce withdrawal symptoms. Used for Opioid use disorder maintenance treatment, Chronic pain management in opioid-tolerant patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}